Document is current
Any future updates will be listed below
-
Authors
Miyashita, Emi https://orcid.org/0009-0007-5300-985X
Onizuka, Kazumitsu https://orcid.org/0000-0001-9713-4619
Chen, Yutong
Yoshida, Hiroki https://orcid.org/0009-0008-8362-7859
Hatayama, Hina
Ishikawa, Shunya
Yan, Peijie
Hasegawa, Takahito
Ozawa, Mamiko
Maeta, Kaho https://orcid.org/0009-0007-5258-8108
Nagatsugi, Fumi https://orcid.org/0000-0002-5526-6020
Saito, Hirohide https://orcid.org/0000-0002-8570-5784
Komatsu, Kaoru R. https://orcid.org/0000-0002-4505-0840
- License Information
-
More Information
Article History
Received: 5 June 2025
Accepted: 18 February 2026
First Online: 19 March 2026
Competing interests
: xFOREST Therapeutics Co., Ltd. has filed a patent application (PCT/JP2022/007117, filed on 22 February 2022) related to the development of BIVID-MaP, and E.M., K.O., F.N., and K.R.K. are named as co-inventors. K.R.K. and H.S. own shares in xFOREST Therapeutics Co., Ltd. H.S. holds a scientific advisory position at xFOREST Therapeutics Co., Ltd.
